ATS 2018 International Conference - Mobile

D12 - IMMUNOTHERAPY IN LUNG DISEASE

Location: PRE-FUNCTION 5-6

Session Type: Mini Symposium

Wednesday

May

23

9:15 AM

11:15 AM

Presentation(s)

Moderator
05-23-2018 9:15 AM - 11:15 AM
The Potential for RORgamma Antagonists to Treat A Sub-Population of Severe Asthma: A Trans...
05-23-2018 9:15 AM - 9:30 AM
Moderator
05-23-2018 9:15 AM - 11:15 AM
Fevipiprant Demonstrates Novel Anti-Inflammatory Effects on Blood and Airway Gene Expressi...
05-23-2018 9:45 AM - 10:00 AM
On-Demand Inhaled Interferon-Beta 1a for the Prevention of Severa Asthma Exacerbations: Re...
05-23-2018 10:00 AM - 10:15 AM
Dupilumab Treatment Produces Rapid and Sustained Improvements in FEV1 in Patients with Unc...
05-23-2018 9:30 AM - 9:45 AM
The RIFF Study (Cohort B): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial ...
05-23-2018 10:45 AM - 11:00 AM
Inhaled PI3Kδ Inhibitor Nemiralisib Improves Lung Function and Reduces Re-Exacerbations in...
05-23-2018 11:00 AM - 11:15 AM
The Effect of Treatment with Omalizumab on Anti-Viral Responses in Adults with Severe Alle...
05-23-2018 10:15 AM - 10:30 AM
The RIFF Study (Cohort A): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial ...
05-23-2018 10:30 AM - 10:45 AM